Federal contract award
75A50223C00037
OVER THE COUNTER (OTC) COVID-19 TESTS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | ASPR/DAAPPO/ORM HQ |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6650 — Optical Instruments, Test Equipment, Components and Accessories |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $61.2M |
| Current contract value | $61.2M |
| Potential contract value / ceiling | $61.2M |
| Start date | Sep 20, 2023 |
| Current end date | Mar 19, 2025 |
| Potential end date | Mar 19, 2025 |
| Latest award activity | Nov 7, 2024 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Nov 7, 2024 | P00004 | $0 | OVER THE COUNTER (OTC) COVID-19 TESTS |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.